AN2 Therapeutics (ANTX) announced a collaboration agreement with GSK (GSK) to develop new therapies for tuberculosis. As part of this effort, the Gates Foundation will provide a third year of funding to support AN2’s work within the collaboration.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANTX: